From this perspective, the MD represents a particularly suitable strategy for patients undergoing pharmacological therapy with GLP-1 RAs such as semaglutide
This hormone plays a crucial role in regulating appetite, food intake, and blood sugar levels
A 2.5 mg dose of tirzepatide and a 0.25 mg dose of semaglutide are both "starting doses" that serve the same purpose, tolerance building, but the actual pharmacology behind each number is unique
You might wonder how much more it can do
It works by slowing digestion, increasing feelings of fullness, and reducing cravings, leading to reduced calorie intake and weight loss
Regular communication with your healthcare provider ensures the best outcomes while minimizing risks